Category Archives: Technology

Alzheimer’s Test Offers Early Diagnosis

By George Koroneos | Published: August 11, 2010
Image via Wikipedia A research team in Belgium discovered a new test that has proven successful at identifying patients that are developing Alzheimer’s disease, according to a report published in the Archives of Neurology on Tuesday. The study took spinal fluid from patients with varying levels of cognitive memory and looked for a specific protein signature or [...]
Also posted in R&D | Tagged , , , , , , , | Leave a comment

Pharma and Cloud Computing: Are We There Yet?

By George Koroneos | Published: June 16, 2010
In the past few years, Microsoft has been working hard to create clinical trial platforms for the pharmaceutical industry. This year, the Redmond, WA-based behemoth has moved full-speed ahead with its virtual-server system, dubbed Azure. Microsoft is not only working on hosted applications, instead the company has established a massive online server or “cloud” that forms [...]
Posted in Technology | Tagged , , , , | Leave a comment

Do You Have a Head of Social Media?

By Julian Upton | Published: April 30, 2010
And do you need one? Julian Upton looks at some of the contrasting ideas that emerged from last month’s Digital Pharma Europe event. If anyone had any lingering doubts about an unprecedented era of inclusion and transparency promised by pharma’s newfound, if tentative, embrace of online social media, then last month’s Digital Pharma Europe conference must [...]
Also posted in E-Media, Europe, Events, Guest Blog, Strategy | Tagged , , , , , | 1 Comment

GSK Signs $120M Deal to Market DMab Overseas

By George Koroneos | Published: July 29, 2009
Image via Wikipedia In an effort to boost its sales force without hiring more sales reps, Amgen announced on Tuesday that it has signed a deal with GlaxoSmithKline to co-market its osteoporosis treatment denosumab—currently pending FDA approval. GSK will paying $120 million up front (along with royalties) to mutually market denosumab, or DMab, in regions where Amgen [...]
Also posted in Deals, News | Tagged , , , , , , , , , , , | Leave a comment

Daiichi Sankyo Chief Talks Effient

By George Koroneos | Published: July 15, 2009
FDA, late Friday, approved Daiichi Sankyo and Eli Lilly’s Effient (prasugrel), a blood thinner designed to lower the chance of blood clots in patients undergoing angioplasty. The drug received a black box warning from the get go, warning doctors of an increased risk of bleeding. However, the fact that the two companies now have a [...]
Also posted in News, Strategy | Tagged , , , , , , | 2 Comments